| Primary information |
|---|
| ID | antitb_1729 |
| Peptide Name | SEQ ID NO 11 |
| Sequence | SEAYQGVQQ |
| N-terminal Modification | Free |
| C-terminal Modification | Free |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Length | 9 |
| Chirality | L |
| Nature | NA |
| Source | Protein Derived |
| Origin | From the proetins containing mycobacterial CD8 T cell epitopes |
| Species | Mycobacterium tuberculosis |
| Strain | Mycobacterium tuberculosis |
| Inhibition Concentartion | NA |
| In vitro/In vivo | In vitro |
| Cell Line | PBMcs |
| Inhibition Concentartion | NA |
| Cytotoxicity | NA |
| In vivo Model | β2-microglobulin gene knowckout mice, TAP-1 null mutant mice and HSP-65 immunized mice |
| Lethal Dose | NA |
| Immune Response | IFN-γ release increases |
| Mechanism of Action | By CD8 T cell response |
| Target | NA |
| Combination Therapy | None |
| Other Activities | None |
| Pubmed ID | US 2002/013197 |
| Year of Publication | 2002 |
| 3-D Structure |  View in Jmol or Download Structure |